|
TNRC18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75545999999693E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.17199999999318E-05 |
| Normal-vs-Stage2 |
4.773700E-02 |
| Normal-vs-Stage3 |
1.31140000003693E-06 |
| Normal-vs-Stage4 |
1.795850E-04 |
| Stage1-vs-Stage2 |
2.391400E-01 |
| Stage1-vs-Stage3 |
8.861800E-02 |
| Stage1-vs-Stage4 |
4.539400E-01 |
| Stage2-vs-Stage3 |
3.442200E-02 |
| Stage2-vs-Stage4 |
1.501000E-01 |
| Stage3-vs-Stage4 |
6.164400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81805999999174E-05 |
| Normal-vs-AfricanAmerican |
1.305420E-01 |
| Normal-vs-Asian |
1.796210E-02 |
| Caucasian-vs-AfricanAmerican |
1.780630E-01 |
| Caucasian-vs-Asian |
2.478400E-01 |
| AfricanAmerican-vs-Asian |
6.822800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.813360E-04 |
| Normal-vs-Female |
1.95155999999086E-05 |
| Male-vs-Female |
8.119800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.960300E-04 |
| Normal-vs-Age(41-60Yrs) |
3.9981999999994E-05 |
| Normal-vs-Age(61-80Yrs) |
9.57619999999437E-05 |
| Normal-vs-Age(81-100Yrs) |
1.386170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.856200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.422400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.758400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.010800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.308000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.519400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.59599999672145E-08 |
| Classical-VS-Follicular |
1.563390E-03 |
| Classical-VS-Other |
4.536400E-01 |
| Classical-VS-Normal |
1.895540E-03 |
| Tall-VS-Follicular |
2.408300E-02 |
| Tall-VS-Other |
2.412600E-01 |
| Tall-VS-Normal |
2.74420042245538E-10 |
| Follicular-VS-Other |
7.675600E-01 |
| Follicular-VS-Normal |
2.11900000002263E-06 |
| Other-VS-Normal |
5.434200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.617400E-04 |
| Normal-vs-N1 |
5.64399999999354E-05 |
| N0-vs-N1 |
3.322000E-01 |
|
|
